This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Strength in partnership The first cohort of ATI trainees embarked on internships at Regeneron Pharmaceuticals in 2021, where Bob McCowan, SVP and CIO, welcomed them onto technical and IT teams. Additionally, organizations can take advantage of bespoke advisory services to implement internal neurodiversity programs.
Pharmaceutical Industry today, is a goldmine of opportunities. The global pharmaceutical market was estimated at approximately $935 billion in 2017 and is bound to reach $1170 billion by 2021. And for a company to succeed, the people who make it, i.e., its employees, should be updated with all the recent developments.
The latest piece in her reinvention story is Synchrony’s new Tech Apprenticeship for Artificial Intelligence, a full-time, 12-month program that balances on-the-job learning with instructor-led training, providing Chavarin with a pathway into one of the most coveted technology spaces despite her very nontraditional IT background.
They integrate with Slack, Microsoft Messenger, and other chat programs where they read the language you use, then turn on when you type in a trigger phrase. That’s why critics say these programs are always listening; if they weren’t, they’d never know when you need them.
Data architect vs. data scientist According to Dataversity , the data architect and data scientist roles are related, but data architects focus on translating business requirements into technology requirements, defining data standards and principles, and building the model-development frameworks for data scientists to use.
Still, software developers seeking to leverage graphics chips for non-graphical applications had to wrangle their calculations into a form that could be sent to the GPU as a series of instructions for either Microsoft’s DirectX graphics API or the open-source OpenGL (Open Graphics Library).
Tadataka Yamada, a pioneer in drug and vaccine development who helped forge numerous biotech companies and spent six years at the Bill and Melinda Gates Foundation as head of global health, died Wednesday morning of natural causes at his home in Seattle. Tadataka “Tachi” Yamada. Twitter Photo via @TachiYamada).
As part of a program designed to accelerate its use of enterprise data and analytics , pharmaceutical titan GlaxoSmithKline (GSK) designed a set of analytics tools focused on inventory reduction opportunities across the company’s supply chain. GSK finds inventory reduction opportunities. Business analytics dashboard components.
While Silicon Valley still pays top dollar for IT pros, the war for talent has moved beyond the technology industry, with other verticals vying for talented IT workers who have the skills to enable digital transformation, process improvement, change management, and the development of apps and services.
The shift in responsibilities Traditionally, control engineers focused on programming PLCs, designing control systems, and ensuring operational efficiency. These developments reflect the growing maturity of the OT cybersecurity field. Training programs: Free resources like those offered by experts such as Mike Holcomb.
NSIN tapped Justin Dunnicliff as its university program director at the UW. He’ll be based at the CoMotion, the university’s innovation hub, and will run programs including Hacking for Defense and Starts. NSIN tapped Justin Dunnicliff as its university program director at the UW. The six-year old company raised $5.5
That’s what happened to a global pharmaceutical company working on a COVID vaccine. “A A lot of pharmaceutical companies used AI to find solutions faster,” says Mario Schlener, global financial services risk leader at Ernst & Young. One company made some good progress in building algorithms, he says. GDPR fines.
The impact of space technology, on other industries, is wide and vast, and the innovation ripple of research has spurred many high-profile products, including Teflon and CAT scans, as well as many more developments from NASA. Then, I will share information about the 2023 SAP Innovation Award program and how companies can get involved.
The role requires expert back-end programming and server configuration skills, as well as knowledge of containers and continuous integration and delivery deployment, Rao says. “An An AI designer works with developers to ensure they understand the needs of human users. AI designer. AI strategist.
The Hangars are developing the next generation of reservation processes, information services, personalization, and self-service tools for the Cologne-headquartered airline, which also operates Austrian Airlines, Brussels Airlines, Eurowings, and Swiss International Air Lines, among others.
The company launched its COVID program in October, supported in part by $10 million from the Bill & Melinda Gates Foundation. Simpson was formerly the CEO of PvP Biologics, another IPD spinout, which he oversaw from the company’s launch through its sale to the pharmaceutical company Takeda.
“The interest in AI that began last year has turned into frenzy as organizations grow even more convinced of its potential to automate everything from business processes and decision-making to software development to creating written content,” Foundry writes in its 2024 CIO Tech Priorities report.
They should be able to work collaboratively with many departments in developing AI strategy and vision, and they should be able to design and target relevant business use cases, assess project outcomes, and measure ROI in each case. They should be a champion for smart AI adoption, and be able to recognize and balance AI benefits with risks.
Managing inventory, both pre-operative and post-operative, is time consuming because the inventory replenishment process is reactive,” says Jim Swanson, CIO at US pharmaceutical and medical technologies company Johnson & Johnson. As an example, Swanson points to total knee arthroplasty (TKA) and total hip arthroplasty (THA) procedures.
This development, announced on February 19 , has wide-reaching implications for industries, enterprises, governments, and, critically, cybersecurity both as an opportunity and a challenge. Pharmaceuticals & biotech: Simulating enzyme interactions for drug discovery, reducing the need for costly trial-and-error experiments.
The startup has an exclusive license to use novel CAR T-cell technology developed by Jensen and his team. “With our clinical trials and our academic programs, we can treat and help dozens or tens of dozens of patients,” Jensen said. Steven Brugger will join BrainChild Bio as CEO.
Throughout my career at Textron, I have had many roles, spanning supply chain, manufacturing, integrated product teams, and working on helicopter programs. That led me into a role in the pharmaceutical industry, again, building and operating processes to manufacture pharmaceuticals. I love the talent philosophy.
The 15-week program targets early stage companies for “cleantech-specific” instruction, mentoring, and support in business planning, manufacturing products, and building a customer base. Participants are from startups that address energy use, toxic chemical removal, biofuels, waste reduction, and other green-leaning technologies.
Early in her career as a program management specialist at AT&T, Balaban became an active member with the Project Management Institute’s New Jersey chapter, which put her front and center at plenty of events. Judy Balaban has seen firsthand how stepping into the professional spotlight, even on a small stage, pays dividends.
The funding for the “Innovation Cluster Accelerator” program is provided through $15 million from the U.S. Washington Autonomous Vehicle Cluster (WAV-C), led by the Kitsap Economic Development Alliance – accelerating the advancement of unpiloted and autonomous vehicles, with an initial focus on the growing need for waterborne craft.
The funding will fuel Alpine’s programdeveloping ALPN-303, designed to treat lupus and other inflammatory diseases. That payment is part of a licensing deal inked last year with the pharmaceutical giant for clinical testing of another immune-modulating agent, ALPN-101, for lupus. million shares of common stock and 3.2
Presage has existing partnerships with healthcare heavy hitters Takeda Pharmaceutical, Celgene and Bristol Myers Squibb (BMS). Fred Hutch roots: Presage launched in 2009 as a Fred Hutchinson Cancer Research Center spinoff built on technology developed by Fred Hutch oncologist Dr. Jim Olson. He became CEO in 2018.
And during his first year, Sanath and Ramya tried so hard to help their son grow and develop like a typical child. And the doctors were able to successfully petition the FDA to let them use another drug that a pharmaceutical company was developing for a different disease. He’s adorable. He needed a feeding tube to eat.
De La Rosa was previously an executive director at Enanta Pharmaceuticals, where he helped clinical development of assets for RSV, SARS-CoV-2, and HBV. De La Rosa also held leadership roles at Abbot, Takeda and Janssen, where he led the development of assets for HIV, HCV, RSV, and the Dengue Tetravalent Vaccine program.
Notch Therapeutics is commercializing technologies developed in the labs of Juan-Carlos Zúñiga-Pflücker, left, chair of Notch’s scientific advisory board, and Chief Scientific Officer Peter Zandstra. The biotech company was founded in 2018 and is developing stem cell-derived immunotherapies for cancer. Notch Photo).
based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. billion if development milestones are met, and another $1.75
ZoomInfo uses machine learning to help customers drive sales and marketing programs and went public last year. Portland-based Sparrow Pharmaceuticals named Robert Jacks its president and CEO after closing a $50 million Series A financing round led by healthcare investment firm OrbiMed. based SaaS company.
Vodafone Automotive developed an innovative program to help insurance companies tailor policies more precisely. Improved safety and compliance Manufacturers in fields like pharmaceuticals and food are keenly aware of the need to keep their customers safe.
Ford previously served as vice president and CISO at Rockwell Automation, with past experience leading security transformation initiatives and developing cybersecurity programs. Impel Pharmaceuticals CFO Michael Kalb is stepping down at the end of this year. Adrian Adams , Impel’s former CEO, resigned last month.
AltPep is developing tools and treatments for diseases caused by amyloid proteins that are incorrectly folded and create harmful deposits. AltPrep is currently focused on Alzheimer’s and developing tools that can detect the illness even before someone is symptomatic. Athira went public last year.
The approval on Monday of the first new drug for Alzheimer’s disease in nearly two decades — Biogen’s aducanumab — helps shine a light on a path forward for other companies developing Alzheimer’s therapies, including Seattle-based Athira Pharma , which saw its stock rise more than 4% off the Biogen news.
“David said, ‘Well, George, if we do this, no one’s going to develop it for you. James and George have assembled a team of world-class scientists and pharmaceutical industry veterans that is able to create new preclinical molecules with extraordinary speed and accuracy,” Picardo said. ” Ueda recalled.
“When I founded the company, I never really expected to get a product on the market to patients,” said Hoekman, who served as CEO until 2017 and is now chief technology and development officer. It’s been a “big challenge to shift from a device technology-focused company to what is now a pretty integrated pharmaceutical company,” said Hoekman.
Black conducted dozens of interviews with epidemiologists around the world to get a sense of the challenges they were facing, and what she heard helped shape the 10 recommendations listed in the paper published today: Support data hygiene and interoperability by developing and adopting a consistent data model.
The new arrangement created a single institution that combined research and patient care and also serves as University of Washington Medicine’s cancer program. AGC Biologics is a “Contract Development and Manufacturing Organization” that helps companies develop and produce pharmaceuticals and other medical treatments.
He co-founded Room on Call (now Hotelopedia) in 2015, where he set up the complete technology infrastructure, development, product management, and operations. He brings expertise in developing IT strategy, digital transformation, AI engineering, process optimization and operations. Web Werks India hires Kamal Goel as director of IT.
In contrast to a linear economy where resources are extracted, used, and tossed in landfills, a circular economy focuses on developing longer-lasting products that can be easily reused, repaired, repurposed and recycled. One possible way to do that is by embracing the idea of a circular economy.
Rubinstein joined Adaptive in 2011 as senior vice president of corporate and business development and became president seven years later. She previously held commercial development roles at Pfizer. Members include: Sonoma co-founder Alexander Rudensky , chair of the immunology program at the Sloan Kettering Institute.
Intrinsic Medicine was founded in 2018 to develop sugar-based molecules matching those in human milk. The SPAC merger would have fueled a phase 2 clinical trial testing an oligosaccharide for patients with irritable bowel syndrome, and supported preclinical programs for atopic dermatitis, autism spectrum disorder, and rheumatoid arthritis.
We organize all of the trending information in your field so you don't have to. Join 83,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content